THERAPEUTIC EFFECTS OF BEZAFIBRATE AND GEMFIBROZIL IN HYPERLIPOPROTEINEMIA TYPE-IIA AND TYPE-IIB

被引：7
|
作者：
KREMER, P [1 ]
MAROWSKI, C [1 ]
JONES, C [1 ]
ACACIA, E [1 ]
机构：
[1] CENT AIR FORCE HOSP,DEPT NUTR & DIABET,CHARCAS 3654 6-A,RA-1425 BUENOS AIRES,ARGENTINA
来源：
CURRENT MEDICAL RESEARCH AND OPINION | 1989年 / 11卷 / 05期
关键词：
D O I：
10.1185/03007998909115212
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：293 / 303
页数：11
相关论文
共 50 条
  • [1] COMPARATIVE-STUDY OF CLOFIBRATE AND BEZAFIBRATE IN HYPERLIPOPROTEINEMIA TYPE-IIA AND TYPE-IIB
    ARNTZ, HR
    KLEMENS, UH
    LANG, PD
    VOLLMAR, J
    [J]. MEDIZINISCHE KLINIK, 1978, 73 (49) : 1731 - 1737
  • [2] HYPERLIPOPROTEINEMIA TYPE-IIA, TYPE-IIB AND TYPE-IV - EFFICACY OF BEZAFIBRATE RETARD ON LIPIDS, LIPOPROTEINS, AND LP(A) THERAPEUTIC NEWS
    SCHWARTZKOPFF, W
    BIMMERMANN, A
    [J]. MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1988, 130 (22): : 422 - 426
  • [3] PLATELET MEMBRANE FLUIDITY IN TYPE-IIA, TYPE-IIB AND TYPE-IV HYPERLIPOPROTEINEMIA
    MALLE, E
    SATTLER, W
    PRENNER, E
    LEIS, HJ
    KARADI, I
    KNIPPING, G
    ROMICS, L
    KOSTNER, GM
    [J]. ATHEROSCLEROSIS, 1991, 87 (2-3) : 159 - 167
  • [4] LONG-TERM TREATMENT OF HYPERLIPOPROTEINEMIA, TYPE-IIA AND TYPE-IIB WITH ETIROXATE
    SCHWARTZKOPFF, W
    RUSS, E
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1975, 100 (15) : 815 - 821
  • [5] DOSAGE-ACTIVITY COMPARISON WITH ETIROXATE HCL IN HYPERLIPOPROTEINEMIA TYPE-IIA AND TYPE-IIB
    BANZ, H
    GALL, FP
    [J]. MEDIZINISCHE KLINIK, 1980, 75 (01) : 51 - 52
  • [6] HEPATOCYTES AND EARLY TYPE-IIA AND TYPE-IIB HYPERLIPOPROTEINEMIAS
    GARIOT, P
    GROSS, P
    FOLIGUET, B
    KOLOPP, M
    BARRAT, E
    POINTEL, JP
    DROUIN, P
    DEBRY, G
    [J]. ANNALES DE BIOLOGIE CLINIQUE, 1985, 43 (04) : 679 - 679
  • [7] CHOLESTYRAMINE, CLOFIBRATE AND NICOTINIC-ACID AS SINGLE OR COMBINED TREATMENT OF TYPE-IIA AND TYPE-IIB HYPERLIPOPROTEINEMIA
    ORO, L
    OLSSON, AG
    ROSSNER, S
    CARLSON, LA
    [J]. POSTGRADUATE MEDICAL JOURNAL, 1975, 51 : 76 - 81
  • [8] CHANGES IN SERUM-LIPOPROTEIN PATTERN FOLLOWING BEZAFIBRATE - DIFFERENTIAL-EFFECTS IN TYPE-IIA AND IN TYPE-IIB HYPERLIPOPROTEINEMIC PATIENTS
    SOMMARIVA, D
    TIRRITO, M
    BONFIGLIOLI, D
    POGLIAGHI, I
    BRANCHI, A
    OTTOMANO, C
    BELLINTANI, L
    [J]. PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1985, 17 (12): : 1181 - 1191
  • [9] RENAL-FUNCTION IN PATIENTS WITH TYPE-IIA AND TYPE-IIB HYPERLIPEMIA
    FERDER, L
    INSERRA, F
    RYBA, D
    DACCORDI, H
    LIPSZYC, P
    [J]. KIDNEY INTERNATIONAL, 1990, 37 (01) : 274 - 274
  • [10] CELL-MEDIATED IMMUNE-RESPONSE IN PATIENTS WITH TYPE-IIA, TYPE-IIB AND TYPE-IV PRIMARY HYPERLIPOPROTEINEMIA
    ANTONACI, S
    JIRILLO, E
    GAROFALO, AR
    POLIGNANO, A
    RESTA, F
    PUGLIESE, P
    CAPURSO, A
    BONOMO, L
    [J]. CYTOBIOS, 1988, 54 (218-19) : 181 - 189
12345